The independent source for health policy research, polling, and news.
29,021 - 29,040 of 112,210 Results
As the outbreak enters its second month, investigators are still scrambling to locate its origin. In other public health news: domestic violence, Alzheimer's, anti-depression medication, eyeglasses, Lyme disease, autism, and more.
Some economists worry that e-visits will actually exacerbate health costs, while doctors are concerned that if the tele-appointments become popular they'll lose valuable face time with their patients.
The model would require the state to get rid of managed care in favor of the state university handling benefits for Medicaid recipients. But Ohio says the move would cost more money than it would save. Medicaid news comes out of Iowa and Connecticut, as well.
Many in the antiabortion movement want the potential case to make it to the Supreme Court, where they see a shot at overturning Roe v. Wade.
Education Secretary Betsy DeVos, whose family invested $100 million in the blood-testing start-up, is just one of the well-known investors that took a chance on what was touted as a Silicon Valley fairy tale.
Many see race as a crucial factor in how Congress and health officials have focused on prevention and education rather than punishment. White victims make up almost 80 percent of the deaths from opioid overdoses, while, in contrast, in 2000, 84 percent of crack cocaine offenders were black. In other news on the crisis: a 25-year-old pill for nerve pain raises some red flags; the DEA issues an immediate suspension of opioid sales by a wholesale distributor; drug distributors head to Capitol Hill; and more.
FDA Commissioner Scott Gottlieb emphasized the need to cut hiring time when it comes to rank-and-file staff positions. At the annual meeting of the Reagan-Udall Foundation for the FDA, Gottlieb also countered criticism of the agency's "breakthrough" designation for certain drugs.
“I’ve never known the enthusiastic mass exodus of an organization’s most knowledgeable and experienced personnel to be an indication that all is well," said John Hoellwarth, a spokesman for Amvets. The VA has been struggling with its leadership at the same time there's been a push to move toward privatization, and the officials on the ground are overwhelmed and understaffed.
Business groups want relief from the mandate, but lawmakers have little appetite to take up any more changes in this politically charged election year. Meanwhile, Idaho officials are still trying to figure out ways to sell plans that don't comply with health law regulations.
This week's planned speech is expected to offer a “comprehensive strategy” that administration officials say will result in a “profound modernization” of how the government pays for some drugs. But the pharma industry is watching anxiously in case President Donald Trump goes off script.
Today's early morning highlights from the major news organizations.
Editorial pages focus on these and other health topics.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Media outlets report on news from Iowa, New Hampshire, California, New York, Colorado, Texas, Georgia, Arizona and Minnesota.
Scientists studying families with migraines find evidence that hundreds of genetic variants can determine the symptoms and severity of the debilitating disease. In other public health news today: brain implants, the CDC's disease detective program, brain trauma, breast cancer and menopause.
Specifically, researchers want to analyze Veterans Affairs data to look for adverse side effects from medications. Meanwhile, the Mayo Clinic is launching its new electronic medical records system.
U.S. District Judge John deGravelles "exaggerated the burden" and "minimized the benefits" of the law when he ruled against it, said Elizabeth Murill of the state attorney general’s office.
The state's House of Representatives voted to extend New Hampshire’s Medicaid expansion program with an added work requirement.
Baltimore's health department and a national advocacy group wrote to the Trump administration asking officials to take action. Meanwhile, Mayor Bill de Blasio wants to make New York City a pioneer in creating supervised safe injection sites.
Despite consumer unease about their DNA privacy, especially on the heels of the Golden State Killer case, Congress has made no moves to update the 2008 Genetic Information Nondiscrimination Act, the lone law in this field.
© 2026 KFF